Research.Patient.info
metastatic or unresectable, recurrent HNSCC research hub
2 indexed studies · 2 currently recruiting
- recruitingTherapeutic exploratory (Phase II)
A PHASE 2 STUDY OF ALX148 IN COMBINATION WITH PEMBROLIZUMAB AND CHEMOTHERAPY IN PATIENTS WITH ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA (ASPEN-04)
This study is testing a new combination of medicines for people with advanced head and neck cancer. It combines an experimental drug called ALX148 with an existing treatment (pembrolizumab) and chemotherapy. Researchers want to see how well this new combination shrinks tumours.
Belgium · Netherlands · Spain - recruitingTherapeutic exploratory (Phase II)
A PHASE 2 STUDY OF ALX148 IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA (ASPEN-03)
This study looks at a new treatment called ALX148 combined with an existing cancer drug, pembrolizumab (Keytruda), for advanced head and neck cancer. Researchers want to see if this combination helps shrink tumours or stop them from growing.
Netherlands · Belgium · Spain